MENU

NGNE Neurogene Forecast, Technical & Fundamental Analysis

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning)... Show more

NGNE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
NGNE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NGNE is expected to report earnings to rise 41.90% to -149 cents per share on November 12

Neurogene NGNE Stock Earnings Reports
Q3'26
Est.
$-1.49
Q2'26
Beat
by $0.38
Q1'26
Missed
by $0.12
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.19
The last earnings report on August 11 showed earnings per share of -104 cents, beating the estimate of -142 cents. With 66.08K shares outstanding, the current market capitalization sits at 521.90M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WFF0.09N/A
+0.97%
WF Holding Limited
DKNG20.530.05
+0.24%
DraftKings
INSP71.07-0.27
-0.38%
Inspire Medical Systems
ECOR7.35-0.14
-1.87%
electroCore
KRUS34.76-2.59
-6.93%
Kura Sushi USA

NGNE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with RCKT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+2.68%
RCKT - NGNE
52%
Loosely correlated
-5.98%
BRNS - NGNE
51%
Loosely correlated
N/A
TSHA - NGNE
49%
Loosely correlated
+0.24%
RNAZ - NGNE
48%
Loosely correlated
N/A
BCYC - NGNE
45%
Loosely correlated
-0.83%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
131
Web
https://www.neurogene.com